Deutsche Bank’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $325K | Buy |
+6,666
| New | +$325K | ﹤0.01% | 2673 |
|
2021
Q2 | – | Sell |
-1,244
| Closed | -$66K | – | 4424 |
|
2021
Q1 | $66K | Sell |
1,244
-109
| -8% | -$5.78K | ﹤0.01% | 4072 |
|
2020
Q4 | $54K | Buy |
1,353
+504
| +59% | +$20.1K | ﹤0.01% | 4006 |
|
2020
Q3 | $48K | Buy |
849
+80
| +10% | +$4.52K | ﹤0.01% | 3838 |
|
2020
Q2 | $57K | Buy |
+769
| New | +$57K | ﹤0.01% | 3689 |
|
2020
Q1 | – | Sell |
-217
| Closed | -$16K | – | 4147 |
|
2019
Q4 | $16K | Buy |
+217
| New | +$16K | ﹤0.01% | 4177 |
|
2019
Q3 | – | Sell |
-438
| Closed | -$14K | – | 4576 |
|
2019
Q2 | $14K | Sell |
438
-3
| -0.7% | -$96 | ﹤0.01% | 4536 |
|
2019
Q1 | $23K | Buy |
+441
| New | +$23K | ﹤0.01% | 4472 |
|
2018
Q4 | – | Sell |
-877
| Closed | -$77K | – | 4670 |
|
2018
Q3 | $77K | Buy |
+877
| New | +$77K | ﹤0.01% | 4380 |
|
2018
Q2 | – | Sell |
-557
| Closed | -$44K | – | 4903 |
|
2018
Q1 | $44K | Sell |
557
-3,442
| -86% | -$272K | ﹤0.01% | 4496 |
|
2017
Q4 | $543K | Sell |
3,999
-4,952
| -55% | -$672K | ﹤0.01% | 3470 |
|
2017
Q3 | $1.45M | Buy |
8,951
+7,148
| +396% | +$1.16M | ﹤0.01% | 2731 |
|
2017
Q2 | $270K | Buy |
1,803
+1,645
| +1,041% | +$246K | ﹤0.01% | 3647 |
|
2017
Q1 | $24K | Sell |
158
-247
| -61% | -$37.5K | ﹤0.01% | 4123 |
|
2016
Q4 | $82K | Buy |
405
+317
| +360% | +$64.2K | ﹤0.01% | 3943 |
|
2016
Q3 | $20K | Buy |
88
+6
| +7% | +$1.36K | ﹤0.01% | 4179 |
|
2016
Q2 | $16K | Buy |
82
+46
| +128% | +$8.98K | ﹤0.01% | 4461 |
|
2016
Q1 | $9K | Sell |
36
-24
| -40% | -$6K | ﹤0.01% | 4486 |
|
2015
Q4 | $20K | Sell |
60
-6
| -9% | -$2K | ﹤0.01% | 4366 |
|
2015
Q3 | $16K | Buy |
66
+8
| +14% | +$1.94K | ﹤0.01% | 4418 |
|
2015
Q2 | $16K | Buy |
+58
| New | +$16K | ﹤0.01% | 4520 |
|